Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2393 (LINC02393), also known as FLJ37505, is a human long intergenic non-coding RNA (lincRNA) located in regions of the genome that do not overlap with protein-coding genes and is longer than 200 nucleotides[1]. LincRNAs represent a major subclass of long non-coding RNAs and are distinguished by their position in the genome (intergenic) relative to protein-coding loci[1]. LincRNAs can have a variety of functions, including regulation of gene expression, chromatin remodeling, RNA stabilization, and serving as enhancers or transcriptional regulators, often in a tissue-specific manner[1]. Only a minority of annotated lincRNAs have been functionally characterized, and there is no direct evidence in current literature or curated databases to suggest that LINC02393 functions as a therapeutic target (such as a receptor, enzyme, transporter, or direct disease marker)[1]. There is also no information indicating that any drugs directly target LINC02393, nor has it been established as a diagnostic or predictive biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2393 (LINC02393).